TTOO - T2 Biosystems Inc
IEX Last Trade
3.2
-0.200 -6.250%
Share volume: 164,241
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.40
-0.20
-5.88%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-16 | 2022-11-14 | 2023-03-31 | 2023-05-22 | 2023-08-08 | 2023-11-15 | 2024-04-01 | 2024-05-06 | |
| Total revenue | 5.911 M | 3.677 M | 5.483 M | 2.078 M | 1.964 M | 1.472 M | 1.679 M | 2.061 M | |
| Cost of revenue | 5.081 M | 6.085 M | 3.730 M | 3.995 M | 4.869 M | 3.925 M | 2.574 M | 4.202 M | |
| Gross profit | 830.000 K | -2.408 M | 1.753 M | -1.917 M | -2.905 M | -2.453 M | -895.000 K | -2.141 M | |
| -390.12% | 172.80% | -209.36% | -51.54% | 15.56% | 63.51% | -139.22% | |||
| Operating expenses | 15.849 M | 13.392 M | 11.273 M | 11.770 M | 10.146 M | 8.643 M | 8.424 M | 10.459 M | |
| Selling general and admin | 7.824 M | 7.017 M | 6.554 M | 7.299 M | 6.296 M | 5.980 M | 5.255 M | 6.738 M | |
| Research and development | 8.025 M | 6.375 M | 4.719 M | 4.471 M | 3.850 M | 2.663 M | 3.169 M | 3.721 M | |
| Total expenses | 20.930 M | 19.477 M | 15.003 M | 15.765 M | 15.015 M | 12.568 M | 10.998 M | 14.661 M | |
| -6.94% | -22.97% | 5.08% | -4.76% | -16.30% | -12.49% | 33.31% | |||
| Operating income | -15.019 M | -15.800 M | -9.520 M | -13.687 M | -13.051 M | -11.096 M | -9.319 M | -12.600 M | |
| Ebit | -15.019 M | -15.800 M | -9.520 M | -13.687 M | -13.051 M | -11.096 M | -9.319 M | -12.600 M | |
| Pretax income | -18.034 M | -17.375 M | -10.099 M | -17.965 M | -6.347 M | -15.425 M | -10.340 M | -13.534 M | |
| -3.65% | -41.88% | 77.89% | -64.67% | 143.03% | -32.97% | 30.89% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -18.034 M | -17.705 M | -10.099 M | -17.965 M | -6.347 M | -15.425 M | -10.340 M | -13.534 M | |
| 1.82% | 42.96% | -77.89% | 64.67% | -143.03% | 32.97% | -30.89% | |||
| Net income | -18.034 M | -17.705 M | -10.099 M | -17.965 M | -6.347 M | -15.425 M | -10.340 M | -13.534 M | |
| 1.82% | 42.96% | -77.89% | 64.67% | -143.03% | 32.97% | -30.89% |